In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl.
作者信息
Terleckyj I A, Heikkila R E
机构信息
Department of Neurology, University of Medicine & Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854.
出版信息
Ann N Y Acad Sci. 1992 May 11;648:365-7. doi: 10.1111/j.1749-6632.1992.tb24584.x.
Abstract
摘要
Zotero 插件